Gary Sánchez‐Gordón
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gary Sánchez‐Gordón has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adela Castelló
Department of Chronic Diseases, National Centre for Epidemiology, Carlos III Institute of Health, Calle de Melchor Fernández Almagro, 5, 28029, Madrid, Spain
1 shared publication - Berta Anta
Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Majadahonda Madrid Spain
1 shared publication - Cristina Barahona-López
Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology, Instituto de Salud Carlos III Madrid Spain
1 shared publication - Elena Plans-Beriso
Department of Epidemiology of Chronic Diseases. National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, 28029, Spain
1 shared publication - Nerea Fernández de Larrea-Baz
Cancer and Environmental Epidemiology Unit, Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III (ISCIII), Avda. Monforte de Lemos, 5, 28029, Madrid, Spain.
1 shared publication - Oscar Millet
Center for Cooperative Research in Biosciences (CIC-BioGUNE), Bizkaia Science and Technology Park, 48160 Derio, Spain
1 shared publication
Latest Publications
- Open Access
- 11 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Biological Signatures of Inflammation Biomarkers Identified Using Data Reduction Methods in Adult Population: A Scoping Review Protocol
Background and Aims: Chronic inflammation contributes to various chronic diseases, emphasizing the need for reliable biomarkers for early detection and understanding its causes. Measuring chronic inflammation poses challenges since most biomarkers are influenced by both acute and chronic states and recent exposures. Joint analysis of inflammatory biomarkers may help identify specific biological signatures linked to chronic inflammation. The scoping review whose protocol is described here, aims to map the existing literature identifying these signatures in adults using data reduction methods in epidemiological studies. Methods: The review will follow the Joanna Briggs Institute methodology and the extension for Scoping Reviews of the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis checklist (PRISMA‐ScR). An electronic search will be performed in Medline (via PubMed) and Embase (via Elsevier) for studies published until October 2023, using relevant terms related to inflammation biomarkers, and data reduction methods. Eligible studies include systematic reviews and primary experimental, quasi‐experimental, and observational research analyzing inflammation biomarkers in blood, urine, or saliva from adults. Studies focused on acute infectious diseases, transient inflammatory conditions, and those not published in English or Spanish will be excluded. Four independent reviewers will conduct a two‐phase screening of studies (title/abstract and full‐text), with a third reviewer resolving disagreements. Data extraction will be handled by one reviewer and verified by another using a predefined form. Results: Findings will be summarized in a PRISMA flowchart. Interactive visual maps will illustrate the identified inflammatory signatures, categorized by study design, data reduction method, population type, and clinical condition. All resources will be publicly available. Conclusion: This review will provide a comprehensive overview of inflammation biomarker signatures derived from data reduction methods while identifying existing knowledge gaps in the field. Scoping Review Registration: This protocol was registered on January 25, 2024, on Open Science Framework ( https://doi.org/10.17605/OSF.IO/85XUF ).
- 11 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Open AccessBiological Signatures of Inflammation Biomarkers Identified Using Data Reduction Methods in Adult Population: A Scoping Review Protocol
Background and Aims: Chronic inflammation contributes to various chronic diseases, emphasizing the need for reliable biomarkers for early detection and understanding its causes. Measuring chronic inflammation poses challenges since most biomarkers are influenced by both acute and chronic states and recent exposures. Joint analysis of inflammatory biomarkers may help identify specific biological signatures linked to chronic inflammation. The scoping review whose protocol is described here, aims to map the existing literature identifying these signatures in adults using data reduction methods in epidemiological studies. Methods: The review will follow the Joanna Briggs Institute methodology and the extension for Scoping Reviews of the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis checklist (PRISMA‐ScR). An electronic search will be performed in Medline (via PubMed) and Embase (via Elsevier) for studies published until October 2023, using relevant terms related to inflammation biomarkers, and data reduction methods. Eligible studies include systematic reviews and primary experimental, quasi‐experimental, and observational research analyzing inflammation biomarkers in blood, urine, or saliva from adults. Studies focused on acute infectious diseases, transient inflammatory conditions, and those not published in English or Spanish will be excluded. Four independent reviewers will conduct a two‐phase screening of studies (title/abstract and full‐text), with a third reviewer resolving disagreements. Data extraction will be handled by one reviewer and verified by another using a predefined form. Results: Findings will be summarized in a PRISMA flowchart. Interactive visual maps will illustrate the identified inflammatory signatures, categorized by study design, data reduction method, population type, and clinical condition. All resources will be publicly available. Conclusion: This review will provide a comprehensive overview of inflammation biomarker signatures derived from data reduction methods while identifying existing knowledge gaps in the field. Scoping Review Registration: This protocol was registered on January 25, 2024, on Open Science Framework ( https://doi.org/10.17605/OSF.IO/85XUF ).